Abstract:Diabetes mellitus, stemming from either insulin resistance or inadequate insulin secretion, represents a complex ailment that results in prolonged hyperglycemia and severe complications. Patients endure severe ramifications such as kidney disease, vision impairment, cardiovascular disorders, and susceptibility to infections, leading to significant physical suffering and imposing substantial socio-economic burdens. This condition has evolved into an increasingly severe health crisis. There is an urgent need to develop new treatments with improved efficacy and fewer adverse effects to meet clinical demands. However, novel drug development is costly, time-consuming, and often associated with side effects and suboptimal efficacy, making it a major challenge. Artificial Intelligence (AI) and Machine Learning (ML) have revolutionized drug development across its comprehensive lifecycle, spanning drug discovery, preclinical studies, clinical trials, and post-market surveillance. These technologies have significantly accelerated the identification of promising therapeutic candidates, optimized trial designs, and enhanced post-approval safety monitoring. Recent advances in AI, including data augmentation, interpretable AI, and integration of AI with traditional experimental methods, offer promising strategies for overcoming the challenges inherent in AI-based drug discovery. Despite these advancements, there exists a notable gap in comprehensive reviews detailing AI and ML applications throughout the entirety of developing medications for diabetes mellitus. This review aims to fill this gap by evaluating the impact and potential of AI and ML technologies at various stages of diabetes mellitus drug development. It does that by synthesizing current research findings and technological advances so as to effectively control diabetes mellitus and mitigate its far-reaching social and economic impacts. The integration of AI and ML promises to revolutionize diabetes mellitus treatment strategies, offering hope for improved patient outcomes and reduced healthcare burdens worldwide.

Artificial intelligence and machine learning in diabetes research

Diabetes management in the era of artificial intelligence

Diabetes and artificial intelligence beyond the closed loop: a review of the landscape, promise and challenges

Artificial intelligence-driven transformations in diabetes care: a comprehensive literature review

Artificial intelligence for diabetes care: current and future prospects

Artificial Intelligence for Diabetes Management and Decision Support: Literature Review

Machine learning in precision diabetes care and cardiovascular risk prediction

Transforming Diabetes Care Through Artificial Intelligence: The Future Is Here

Artificial Intelligence in Diabetes Management: Revolutionizing the Diagnosis of Diabetes Mellitus; a Literature Review

Artificial intelligence in diabetes management: Advancements, opportunities, and challenges

Artificial Intelligence in Current Diabetes Management and Prediction

Artificial intelligence for diabetic care

Recent progress in artificial intelligence and machine learning for novel diabetes mellitus medications development

Utilizing Artificial Intelligence Among Patients With Diabetes: A Systematic Review and Meta-Analysis

Artificial intelligence in endocrinology: a comprehensive review

Artificial Intelligence Algorithms for Treatment of Diabetes

AI-based diabetes care: risk prediction models and implementation concerns

Type 2 Diabetes with Artificial Intelligence Machine Learning: Methods and Evaluation

A comprehensive review of machine learning techniques on diabetes detection

Towards Personalized AI-Based Diabetes Therapy: A Review

Need for an Artificial Intelligence-based Diabetes Care Management System in India and the United States